This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| MERS | 5464 |
| CoV | 3350 |
| East | 2438 |
| Middle | 2412 |
| SARS | 1077 |
| Saudi | 684 |
| Arabia | 673 |
| Korea | 418 |
| RNA | 363 |
| Respiratory | 351 |
| Syndrome | 343 |
| Coronavirus | 320 |
| Health | 258 |
| South | 253 |
| PCR | 237 |
| S | 223 |
| RBD | 214 |
| ICU | 213 |
| DPP4 | 203 |
| Fig | 185 |
| CoV-2 | 182 |
| IFN | 172 |
| United | 155 |
| CoV. | 138 |
| China | 129 |
| World | 122 |
| S1 | 119 |
| May | 116 |
| Africa | 114 |
| Hospital | 110 |
| Organization | 108 |
| KSA | 108 |
| Egypt | 108 |
| COVID-19 | 107 |
| Al | 106 |
| sera | 104 |
| CoVs | 99 |
| Jordan | 97 |
| Arab | 97 |
| Arabian | 95 |
| WHO | 93 |
| Peninsula | 93 |
| Disease | 91 |
| Republic | 90 |
| Jeddah | 88 |
| Table | 82 |
| ACE2 | 76 |
| C | 76 |
| RT | 75 |
| M | 75 |
| Infection | 74 |
| Kingdom | 72 |
| Food | 72 |
| Qatar | 68 |
| April | 68 |
| Emirates | 67 |
| Ministry | 67 |
| June | 66 |
| II | 66 |
| Hajj | 66 |
| CT | 65 |
| PPE | 64 |
| Control | 64 |
| A | 63 |
| USA | 62 |
| September | 62 |
| Ebola | 62 |
| EMC | 61 |
| CDC | 61 |
| States | 59 |
| International | 59 |
| Prevention | 58 |
| ELISA | 58 |
| HCoV | 58 |
| mAbs | 58 |
| TM | 58 |
| S. | 56 |
| Riyadh | 55 |
| Medical | 55 |
| AOM | 55 |
| Pakistan | 54 |
| OC43 | 54 |
| US | 53 |
| S2 | 53 |
| WNV | 53 |
| • | 52 |
| National | 51 |
| sha | 50 |
| Europe | 49 |
| Center | 49 |
| N | 48 |
| DC | 48 |
| Wuhan | 48 |
| ORF | 47 |
| Transmission | 46 |
| T | 45 |
| M. | 45 |
| Iran | 45 |
| IgA | 45 |
| HCWs | 45 |
| Oman | 44 |
| Global | 43 |
| Dromedary | 43 |
| Department | 43 |
| March | 42 |
| east | 41 |
| Turkey | 41 |
| July | 41 |
| IgG | 41 |
| Care | 41 |
| Salmonella | 40 |
| DOI | 39 |
| Abu | 39 |
| CFR | 39 |
| middle | 39 |
| Dhabi | 39 |
| Lebanon | 39 |
| OME | 38 |
| IFA | 38 |
| Research | 37 |
| OM | 37 |
| Israel | 37 |
| ARDS | 37 |
| Infectious | 36 |
| Bahrain | 36 |
| Clinical | 36 |
| Human | 36 |
| CI | 36 |
| Laboratory | 36 |
| UAE | 36 |
| University | 36 |
| PLpro | 36 |
| mg | 35 |
| Treatment | 35 |
| Asia | 35 |
| Serologic | 34 |
| January | 34 |
| FAO | 33 |
| Viral | 33 |
| FDA | 33 |
| ritonavir | 32 |
| West | 32 |
| Outbreak | 32 |
| MERS- | 32 |
| February | 32 |
| Committee | 32 |
| Ribavirin | 31 |
| Coronaviruses | 31 |
| Diseases | 31 |
| lopinavir | 31 |
| mofetil | 31 |
| TMPRSS2 | 30 |
| Science | 30 |
| North | 30 |
| Kuwait | 30 |
| Influenza | 30 |
| Hong | 30 |
| Association | 30 |
| Animal | 30 |
| Iraq | 29 |
| B | 29 |
| CD26 | 29 |
| HCP | 29 |
| August | 29 |
| October | 29 |
| Vero | 29 |
| rRT | 29 |
| Region | 29 |
| mycophenolate | 28 |
| H1N1 | 28 |
| E | 28 |
| Dipeptidyl | 28 |
| DNA | 28 |
| Camels | 28 |
| IV | 27 |
| Acute | 27 |
| Antibodies | 27 |
| vivo | 27 |
| L | 27 |
| LRT | 27 |
| J | 26 |
| DCs | 26 |
| Development | 26 |
| EU | 26 |
| France | 26 |
| Investigation | 26 |
| Kong | 26 |
| New | 26 |
| Nile | 26 |
| Patient | 26 |
| Yemen | 26 |
| m336 | 26 |
| E. | 25 |
| City | 25 |
| December | 25 |
| European | 25 |
| Evaluation | 25 |
| Risk | 25 |
| Gulf | 24 |
| CA | 24 |
| Detection | 24 |
| Dubai | 24 |
| Group | 24 |
| Emerging | 24 |
| HKU1 | 24 |
| IL-4 | 24 |
| Kim | 24 |
| Korean | 24 |
| Public | 24 |
| NL63 | 23 |
| C. | 23 |
| EMC/2012 | 23 |
| Family | 23 |
| November | 23 |
| Safety | 23 |
| TCID | 23 |
| β | 23 |
| Healthcare | 22 |
| CMV | 22 |
| Case | 22 |
| Centers | 22 |
| Cross | 22 |
| Dis | 22 |
| Eastern | 22 |
| N95 | 22 |
| Syria | 22 |
| Netherlands | 22 |
| γ | 22 |
| Virus | 22 |
| mRNA | 22 |
| ribavirin | 22 |
| Society | 22 |
| Isolation | 21 |
| Centre | 21 |
| Institute | 21 |
| King | 21 |
| URT | 21 |
| α | 21 |
| MEE | 20 |
| Camelus | 20 |
| Canary | 20 |
| Cas9 | 20 |
| Emirate | 20 |
| HKU5 | 20 |
| HR1 | 20 |
| HR2 | 20 |
| PubMed | 20 |
| Medicine | 20 |
| Novel | 20 |
| OIE | 20 |
| Study | 20 |
| Unit | 20 |
| nucleocapsid | 20 |
| upE | 20 |
| Emergency | 19 |
| Analysis | 19 |
| Arabi | 19 |
| ECMO | 19 |
| Data | 19 |
| Germany | 19 |
| Presence | 19 |
| meta | 19 |
| Humans | 19 |
| Islands | 18 |
| Ahmed | 18 |
| CRISPR | 18 |
| England | 18 |
| IRF3 | 18 |
| HCoVs | 18 |
| Nations | 18 |
| Structure | 18 |
| UK | 18 |
| hepatitis | 18 |
| lymphopenia | 18 |
| IQR | 17 |
| Ad | 17 |
| Agriculture | 17 |
| Assessment | 17 |
| Assiri | 17 |
| Australia | 17 |
| Commons | 17 |
| Creative | 17 |
| Use | 17 |
| IgM | 17 |
| Inhibition | 17 |
| NHP | 17 |
| Nigeria | 17 |
| RdRp | 17 |
| State | 17 |
| betacoronavirus | 17 |
| catarrhalis | 17 |
| Antibody | 16 |
| Camel | 16 |
| Betacoronavirus | 16 |
| HKU4 | 16 |
| America | 16 |
| APACHE | 16 |
| 2c | 16 |
| Congo | 16 |
| interferon | 16 |
| Mouse | 16 |
| Staphylococcus | 16 |
| TNF | 16 |
| Team | 16 |
| bronchoalveolar | 16 |
| κB | 16 |
| ORF1a | 16 |
| Memish | 15 |
| Authority | 15 |
| BALB | 15 |
| Broad | 15 |
| GCC | 15 |
| MRI | 15 |
| Madinah | 15 |
| MNT | 15 |
| Note | 15 |
| Park | 15 |
| RSV | 15 |
| Report | 15 |
| Seroepidemiology | 15 |
| Spike | 15 |
| fi | 15 |
| PBS | 15 |
| Intensive | 14 |
| News | 14 |
| MVA | 14 |
| Lopinavir | 14 |
| Japan | 14 |
| Italy | 14 |
| Crimean | 14 |
| HCoV-229E | 14 |
| Epidemiology | 14 |
| DDP4 | 14 |
| Blueprint | 14 |
| Ankara | 14 |
| R&D | 14 |
| PFA | 14 |
| H. | 14 |
| ROK | 14 |
| signifi | 14 |
| Remdesivir | 14 |
| hCoV | 14 |
| U.S. | 14 |
| U | 14 |
| Technical | 14 |
| Toronto | 14 |
| Summary | 14 |
| Sudan | 14 |
| Severe | 14 |
| Sera | 14 |
| Review | 14 |
| Response | 14 |
| DMEM | 13 |
| Geneva | 13 |
| GM | 13 |
| Fc | 13 |
| Epidemiological | 13 |
| Daejeon | 13 |
| < | 13 |
| Coronaviridae | 13 |
| Comparative | 13 |
| Children | 13 |
| Azhar | 13 |
| Associated | 13 |
| Ali | 13 |
| HIV | 13 |
| Greece | 13 |
| IHC | 13 |
| Host | 13 |
| Omrani | 13 |
| kg | 13 |
| India | 13 |
| Somalia | 13 |
| Seoul | 13 |
| Pipistrellus | 13 |
| alfa-2a | 13 |
| OE | 13 |
| MOH | 13 |
| MENA | 13 |
| MDA5 | 13 |
| Interferon | 13 |
| Infections | 13 |
| L. | 12 |
| Afghanistan | 12 |
| Arabs | 12 |
| Assays | 12 |
| COV | 12 |
| Golgi | 12 |
| Guidelines | 12 |
| HCA | 12 |
| IPC | 12 |
| Index | 12 |
| hyperimmune | 12 |
| Lack | 12 |
| aOR | 12 |
| diff | 12 |
| corona | 12 |
| alpha2b | 12 |
| cov | 12 |
| PAPR | 12 |
| Otitis | 12 |
| NIH | 12 |
| Meeting | 12 |
| Canada | 11 |
| Factors | 11 |
| Ethiopia | 11 |
| ER | 11 |
| Drug | 11 |
| Day | 11 |
| Council | 11 |
| Ang | 11 |
| Campylobacter | 11 |
| C57BL/6 | 11 |
| Bangladesh | 11 |
| IL-6 | 11 |
| Administration | 11 |
| Abdulaziz | 11 |
| ASOM | 11 |
| Haemophilus | 11 |
| Consortium | 11 |
| IL-8 | 11 |
| Spain | 11 |
| J. | 11 |
| β1b | 11 |
| mastoiditis | 11 |
| a2b | 11 |
| Vaccine | 11 |
| Union | 11 |
| Tertiary | 11 |
| ± | 11 |
| Singapore | 11 |
| R. | 11 |
| Pathogenesis | 11 |
| Molecular | 11 |
| MA | 11 |
| Rapid | 11 |
| Li | 11 |
| IL-10 | 10 |
| HAV | 10 |
| HCW | 10 |
| HR2P | 10 |
| Haagmans | 10 |
| ID | 10 |
| Interim | 10 |
| Interhuman | 10 |
| Journal | 10 |
| Kinetics | 10 |
| LDH | 10 |
| English | 10 |
| General | 10 |
| Makkah | 10 |
| El | 10 |
| Dr. | 10 |
| D. | 10 |
| Chronic | 10 |
| Chinese | 10 |
| Central | 10 |
| Cell | 10 |
| Bisha | 10 |
| Beijing | 10 |
| Agency | 10 |
| AH | 10 |
| AE | 10 |
| Life | 10 |
| marmoset | 10 |
| Mary | 10 |
| Surveillance | 10 |
| Med | 10 |
| serologic | 10 |
| protein | 10 |
| pneumocytes | 10 |
| n3/2012 | 10 |
| favipiravir | 10 |
| dipeptidyl | 10 |
| a1111111111 | 10 |
| Zoonotic | 10 |
| Valley | 10 |
| UnitedArabEmirates | 10 |
| Tunisia | 10 |
| β1a | 10 |
| Security | 10 |
| Press | 10 |
| SaudiArabia | 10 |
| Morocco | 10 |
| NAAT | 10 |
| P. | 10 |
| Nipah | 10 |
| Pyeongtaek | 10 |
| Qiagen | 10 |
| R | 10 |
| SP | 10 |
| Mediterranean | 10 |
| IL-12 | 9 |
| GLS-5300 | 9 |
| H5N1 | 9 |
| I | 9 |
| I. | 9 |
| MEW | 9 |
| Immunogenicity | 9 |
| Knowledge | 9 |
| MERS-4 | 9 |
| First | 9 |
| Malaysia | 9 |
| G | 9 |
| County | 9 |
| ED | 9 |
| Dromedaries | 9 |
| D | 9 |
| Crystal | 9 |
| Clinicopathologic | 9 |
| Chan | 9 |
| CD4 | 9 |
| BCX4430 | 9 |
| Ain | 9 |
| AST | 9 |
| ASO | 9 |
| Organisation | 9 |
| NP | 9 |
| Identification | 9 |
| P6 | 9 |
| Tg | 9 |
| Pa | 9 |
| pseudoparticle | 9 |
| nan | 9 |
| metapneumovirus | 9 |
| gure | 9 |
| coronaviruses | 9 |
| Wit | 9 |
| Wang | 9 |
| WBC | 9 |
| VCF | 9 |
| Upper | 9 |
| hDPP4 | 9 |
| Technologies | 9 |
| Red | 9 |
| Patients | 9 |
| St. | 9 |
| Pre | 9 |
| RBM | 9 |
| Preparedness | 9 |
| Replication | 9 |
| Samsung | 9 |
| Scientific | 9 |
| Shigella | 9 |
| Spread | 9 |
| F | 8 |
| Histopathology | 8 |
| Genbank | 8 |
| Genome | 8 |
| Grant | 8 |
| Guangdong | 8 |
| H | 8 |
| HKU5.2N | 8 |
| Hafr | 8 |
| Kawasaki | 8 |
| IDEP | 8 |
| III | 8 |
| Institutes | 8 |
| Institutional | 8 |
| LD | 8 |
| Laikipia | 8 |
| London | 8 |
| Erasmus | 8 |
| Escherichia | 8 |
| B. | 8 |
| Epidemic | 8 |
| Emerg | 8 |
| MERS‐CoV | 8 |
| A. | 8 |
| ADA | 8 |
| Abdullah | 8 |
| Alert | 8 |
| Americas | 8 |
| Angiotensin | 8 |
| Biotechnology | 8 |
| CD8 | 8 |
| CSF | 8 |
| Cairo | 8 |
| Carlsbad | 8 |
| ChAdOx1 | 8 |
| Contact | 8 |
| Corticosteroid | 8 |
| Covid-19 | 8 |
| E6 | 8 |
| M2 | 8 |
| Rift | 8 |
| Management | 8 |
| Southern | 8 |
| Taiwan | 8 |
| Technology | 8 |
| UN | 8 |
| Umrah | 8 |
| Vol | 8 |
| Zaki | 8 |
| benefi | 8 |
| board | 8 |
| doc_id | 8 |
| multiorgan | 8 |
| parainfluenza | 8 |
| peptidase | 8 |
| pp1a | 8 |
| pp1ab | 8 |
| remdesivir | 8 |
| van | 8 |
| Model | 8 |
| T. | 8 |
| microneutralisation | 8 |
| SD | 8 |
| Pediatric | 8 |
| SCH | 8 |
| NF | 8 |
| NHPs | 8 |
| Nidovirales | 8 |
| ORF1b | 8 |
| Outcomes | 8 |
| POC | 8 |
| Otolaryngologic | 8 |
| Pneumonia | 8 |
| Product | 8 |
| Punjab | 8 |
| Receptor | 8 |
| Respir | 8 |
| α2a | 8 |
| Pediatrics | 8 |
| Roche | 8 |
| Dr | 7 |
| GABHS | 7 |
| GS-5734 | 7 |
| GISAID | 7 |
| GD27 | 7 |
| Efficacy | 7 |
| Figure | 7 |
| Falzarano | 7 |
| FASTA | 7 |
| Gaps | 7 |
| Galaxy | 7 |
| Kenya | 7 |
| Geographic | 7 |
| Hasa | 7 |
| Horn | 7 |
| IC | 7 |
| Illumina | 7 |
| Immunohistochemical | 7 |
| Inovio | 7 |
| Island | 7 |
| Ki | 7 |
| Discovery | 7 |
| Disorders | 7 |
| Agricultural | 7 |
| Diagnostics | 7 |
| BSL3 | 7 |
| ADFCA | 7 |
| ALT | 7 |
| AUC | 7 |
| Mackay | 7 |
| Akhtar | 7 |
| Animals | 7 |
| Anon | 7 |
| Arden | 7 |
| BAL | 7 |
| BatCoV | 7 |
| David | 7 |
| Batin | 7 |
| Branch | 7 |
| CD147 | 7 |
| CDC2-C2 | 7 |
| Cases | 7 |
| Commission | 7 |
| Community | 7 |
| Corona | 7 |
| DPP | 7 |
| MERS-0 | 7 |
| HN | 7 |
| Mali | 7 |
| Sultan | 7 |
| Time | 7 |
| Tylonycteris | 7 |
| V | 7 |
| Veterinary | 7 |
| Zika | 7 |
| camostat | 7 |
| committee | 7 |
| coronavirus | 7 |
| coronovirus | 7 |
| dromedaries | 7 |
| ed | 7 |
| hDPP4-Tg | 7 |
| hematoxylin | 7 |
| mL | 7 |
| palatine | 7 |
| pseudotyped | 7 |
| qRT | 7 |
| review | 7 |
| subgenomic | 7 |
| www.nature.com/scientificreports/ | 7 |
| Mecca | 7 |
| Testing | 7 |
| endosomal | 7 |
| Sub | 7 |
| NTD | 7 |
| Mers | 7 |
| Service | 7 |
| Moderna | 7 |
| Modjarrad | 7 |
| Mohamed | 7 |
| Mohammed | 7 |
| Moraxella | 7 |
| Mortality | 7 |
| NALT | 7 |
| Mohd | 7 |
| ORF4a | 7 |
| PL(pro | 7 |
| Philippines | 7 |
| Presentation | 7 |
| Primary | 7 |
| Regional | 7 |
| Rotterdam | 7 |
| SDB | 7 |
| SE | 7 |
| Scopus | 7 |
| Hendra | 6 |
| ILAS | 6 |
| IL-2 | 6 |
| IHR | 6 |
| IFNα | 6 |
| IFN- | 6 |
| H7N9 | 6 |
| HKU5.2 | 6 |
| HAdV | 6 |
| 6 | |
| H&E | 6 |
| IRB | 6 |
| Guide | 6 |
| ILI | 6 |
| LOS | 6 |
| IRF7 | 6 |
| ISARIC | 6 |
| ISRE | 6 |
| Ill | 6 |
| Immunization | 6 |
| Impact | 6 |
| Inc. | 6 |
| KCDC | 6 |
| Klebsiella | 6 |
| Lee | 6 |
| Liu | 6 |
| MCA1 | 6 |
| MMF | 6 |
| Genomic | 6 |
| Ghana | 6 |
| Biosafety | 6 |
| Gene | 6 |
| Fisher | 6 |
| Measles | 6 |
| Ahsa | 6 |
| Asymptomatic | 6 |
| BSL-3 | 6 |
| Bart | 6 |
| Bat | 6 |
| Bin | 6 |
| Borne | 6 |
| Burkina | 6 |
| CCHF | 6 |
| CNS | 6 |
| Chest | 6 |
| Clinic | 6 |
| Cluster | 6 |
| Co | 6 |
| Co. | 6 |
| Cochrane | 6 |
| Corman | 6 |
| Critical | 6 |
| DAD | 6 |
| Declaration | 6 |
| EBV | 6 |
| EC50 | 6 |
| Epidemiologic | 6 |
| Evolution | 6 |
| Faso | 6 |
| Fever | 6 |
| MN | 6 |
| Prophylaxis | 6 |
| Microbiology | 6 |
| Vector | 6 |
| SARI | 6 |
| SFDA | 6 |
| Saharan | 6 |
| Sciences | 6 |
| Sha | 6 |
| Systematic | 6 |
| TGF | 6 |
| Taif | 6 |
| Tawfiq | 6 |
| Thailand | 6 |
| UTR | 6 |
| VARV | 6 |
| Valencia | 6 |
| Welfare | 6 |
| Rep | 6 |
| York | 6 |
| amoxicillin | 6 |
| i.n | 6 |
| m102.4 | 6 |
| mRNAs | 6 |
| n=40 | 6 |
| pH | 6 |
| peptidase-4 | 6 |
| pseudovirus | 6 |
| stridor | 6 |
| −/− | 6 |
| Military | 6 |
| −80 | 6 |
| Roadmap | 6 |
| eff | 6 |
| Recovery | 6 |
| Organ | 6 |
| Multifacility | 6 |
| Recombinant | 6 |
| Mumtaz | 6 |
| Municipality | 6 |
| Mycophenolate | 6 |
| NS4b | 6 |
| NY | 6 |
| Network | 6 |
| Nitazoxanide | 6 |
| OD | 6 |
| ORF5 | 6 |
| Office | 6 |
| NDM-1 | 6 |
| Origin | 6 |
| Program | 6 |
| Raj | 6 |
| RNase | 6 |
| PRRs | 6 |
| Protection | 6 |
| Project | 6 |
| Ministries | 6 |
| Predictors | 6 |
| Pharmaceuticals | 6 |
| People | 6 |
| Palestine | 6 |
| PTSM | 6 |
| Fahad | 5 |
| HCV | 5 |
| Gibco | 5 |
| GenBank | 5 |
| G. | 5 |
| Foundation | 5 |
| Foodborne | 5 |
| Findings | 5 |
| Farag | 5 |
| Engineering | 5 |
| Estimation | 5 |
| HPAI | 5 |
| Down | 5 |
| Eagle | 5 |
| ERK | 5 |
| Dulbecco | 5 |
| Du | 5 |
| Dpp4 | 5 |
| Dorzi | 5 |
| Dynamics | 5 |
| Jeddah-2014 | 5 |
| Hosani | 5 |
| Hu | 5 |
| Kurono | 5 |
| Doha | 5 |
| Koopmans | 5 |
| Khan | 5 |
| Khalid | 5 |
| KI | 5 |
| Joseph | 5 |
| Jiang | 5 |
| Invitrogen | 5 |
| Initiative | 5 |
| Induction | 5 |
| Immune | 5 |
| ISIS | 5 |
| ISGs | 5 |
| IC50 | 5 |
| Hydroxychloroquine | 5 |
| Hussain | 5 |
| Doremalen | 5 |
| ArcGIS | 5 |
| Division | 5 |
| Biosystems | 5 |
| Balkhy | 5 |
| BMJ | 5 |
| BCoV | 5 |
| BACKGROUND | 5 |
| Asan | 5 |
| Anti | 5 |
| American | 5 |
| Aerosol | 5 |
| Ad5 | 5 |
| Acinetobacter | 5 |
| Access | 5 |
| Academy | 5 |
| ABSL-3 | 5 |
| 8) | 5 |
| 3b | 5 |
| 2b | 5 |
| LLC | 5 |
| Biological | 5 |
| Bourbon | 5 |
| Diversity | 5 |
| CC50 | 5 |
| Distress | 5 |
| DOH | 5 |
| Ct | 5 |
| Cov | 5 |
| Complete | 5 |
| Command | 5 |
| College | 5 |
| Coalition | 5 |
| CoV)-update | 5 |
| Clustal | 5 |
| Chen | 5 |
| CYSSLILDY | 5 |
| CRP | 5 |
| COVID‐19 | 5 |
| CKD | 5 |
| CEPI | 5 |
| CCU | 5 |
| LCA60 | 5 |
| beta1b | 5 |
| Laboratories | 5 |
| Van | 5 |
| association | 5 |
| acid | 5 |
| Zarqa | 5 |
| Year | 5 |
| Working | 5 |
| Wei | 5 |
| WFP | 5 |
| Viruses | 5 |
| Times | 5 |
| Screening | 5 |
| Target | 5 |
| Tabuk | 5 |
| Supplementary | 5 |
| Super | 5 |
| Sun | 5 |
| Studies | 5 |
| Stability | 5 |
| Smallpox | 5 |
| azithromycin | 5 |
| beta-1b | 5 |
| bocavirus | 5 |
| camelid | 5 |
| Lahore | 5 |
| ␣ | 5 |
| μg | 5 |
| | | 5 |
| veli | 5 |
| tympanometry | 5 |
| specifi | 5 |
| s.c | 5 |
| rhesus | 5 |
| p.i | 5 |
| mm | 5 |
| mid | 5 |
| lavage | 5 |
| heptad | 5 |
| health | 5 |
| fl | 5 |
| confi | 5 |
| Sharing | 5 |
| monocyte | 5 |
| School | 5 |
| PRNT | 5 |
| Operations | 5 |
| Omega | 5 |
| Nubia | 5 |
| Nature | 5 |
| Mucosal | 5 |
| Meta | 5 |
| Marmoset | 5 |
| MF59 | 5 |
| MERScoronavirus | 5 |
| MERS-27 | 5 |
| MEEs | 5 |
| Load | 5 |
| List | 5 |
| Level | 5 |
| Leishmania | 5 |
| SSYA10 | 5 |
| Lassa | 5 |
| Oxford | 5 |
| Lung | 5 |
| Peptidase | 5 |
| RM | 5 |
| SAS | 5 |
| Pilgrims | 5 |
| SNP | 5 |
| SARS)-CoV | 5 |
| Ritonavir | 5 |
| Release | 5 |
| Regulations | 5 |
| Recommendations | 5 |
| Reusken | 5 |
| RAS | 5 |
| Programme | 5 |
| Pseudomonas | 5 |
| Protocol | 5 |
| Price | 5 |
| Prophylactic | 5 |
| Progress | 5 |
| Prince | 5 |
| Hunter | 4 |
| ICUs | 4 |
| IIFT | 4 |
| IL-17 | 4 |
| IL-5 | 4 |
| Illness | 4 |
| IP-10 | 4 |
| Intranasal | 4 |
| Imported | 4 |
| Inflammatory | 4 |
| Inhibitors | 4 |
| Hospitalized | 4 |
| Interaction | 4 |
| Huang | 4 |
| Galveston | 4 |
| Hodgkin | 4 |
| Heartland | 4 |
| HDR | 4 |
| H5 | 4 |
| Guideline | 4 |
| GraphPad | 4 |
| Genetic | 4 |
| GAA | 4 |
| Fund | 4 |
| Fouchier | 4 |
| Figure-4 | 4 |
| Feasibility | 4 |
| Favipiravir | 4 |
| JEP | 4 |
| Fatal | 4 |
| Islam | 4 |
| Majumder | 4 |
| Jan | 4 |
| MK2 | 4 |
| ExoN | 4 |
| MuA | 4 |
| Mongolia | 4 |
| Mix | 4 |
| Missouri | 4 |
| Microsoft | 4 |
| Media | 4 |
| Mechanisms | 4 |
| Matthew | 4 |
| Mastoiditis | 4 |
| Master | 4 |
| Malik | 4 |
| Mahmoud | 4 |
| MEM | 4 |
| Ji | 4 |
| MAPK | 4 |
| M1 | 4 |
| Ltd. | 4 |
| Long | 4 |
| Livestock | 4 |
| Lethal | 4 |
| Legionella | 4 |
| Large | 4 |
| Lancet | 4 |
| La | 4 |
| Kerkhove | 4 |
| K | 4 |
| John | 4 |
| Faden | 4 |
| Bacillus | 4 |
| Excel | 4 |
| Anonymous | 4 |
| Candida | 4 |
| CXR | 4 |
| Brazil | 4 |
| Board | 4 |
| Beirut | 4 |
| Beigel | 4 |
| BEAST | 4 |
| Attribution | 4 |
| Athens | 4 |
| Assembly | 4 |
| Army | 4 |
| Areas | 4 |
| Applied | 4 |
| Amman | 4 |
| Cheng | 4 |
| Allergy | 4 |
| Alisporivir | 4 |
| Affairs | 4 |
| Adney | 4 |
| Adenosine | 4 |
| Activation | 4 |
| Achilles | 4 |
| Abur | 4 |
| ATPase | 4 |
| AKT | 4 |
| AIDS | 4 |
| ABC | 4 |
| Muscat | 4 |
| Characteristics | 4 |
| Chi | 4 |
| Evolutionary | 4 |
| Drosten | 4 |
| Estimating | 4 |
| Environmental | 4 |
| Environment | 4 |
| Emergomyces | 4 |
| Embase | 4 |
| Elamin | 4 |
| Egyptians | 4 |
| Education | 4 |
| Economic | 4 |
| EVD | 4 |
| ELECTRONIC | 4 |
| ECDC | 4 |
| EC | 4 |
| Distinct | 4 |
| Chloroquine | 4 |
| Daily | 4 |
| DPBS | 4 |
| Cyprus | 4 |
| Cos-7 | 4 |
| Corti | 4 |
| Core | 4 |
| Common | 4 |
| Collection | 4 |
| Cockrell | 4 |
| Clade | 4 |
| Citation | 4 |
| Circulation | 4 |
| Choi | 4 |
| Multiplex | 4 |
| Real | 4 |
| Mustafa | 4 |
| TX | 4 |
| eosin | 4 |
| en/ | 4 |
| defensins | 4 |
| deaminase | 4 |
| cyclophilin | 4 |
| author(s | 4 |
| alphacoronavirus | 4 |
| alfa | 4 |
| aids | 4 |
| Ziad | 4 |
| Zhang | 4 |
| Yu | 4 |
| Young | 4 |
| Yang | 4 |
| Xu | 4 |
| XYH | 4 |
| Workers | 4 |
| Virol | 4 |
| Vespertilio | 4 |
| Vaccines | 4 |
| Ultrastructural | 4 |
| Type | 4 |
| Trizol | 4 |
| Thrombocytopenia | 4 |
| Thompson | 4 |
| Therapy | 4 |
| Tcell | 4 |
| Taxonomy | 4 |
| Task | 4 |
| gammacoronavirus | 4 |
| griffithsin | 4 |
| helicase | 4 |
| pancoronavirus | 4 |
| Mycobacterium | 4 |
| ward | 4 |
| trimeric | 4 |
| tachypnea | 4 |
| syndrome | 4 |
| supraglottitis | 4 |
| superans | 4 |
| submucosal | 4 |
| st | 4 |
| siRNA | 4 |
| rhinorrhea | 4 |
| range | 4 |
| peptidic | 4 |
| p<0.01 | 4 |
| human | 4 |
| otalgia | 4 |
| nucleoprotein | 4 |
| nelfinavir | 4 |
| nafamostat | 4 |
| myringotomy | 4 |
| mmol | 4 |
| mers | 4 |
| mAb | 4 |
| lymphocytopenia | 4 |
| jejuni | 4 |
| intranasal | 4 |
| i.m | 4 |
| hydroxychloroquine | 4 |
| Tanyeri | 4 |
| qPCR | 4 |
| TSI | 4 |
| One | 4 |
| Plan | 4 |
| Physiology | 4 |
| Phylogenetic | 4 |
| Pfi | 4 |
| Peter | 4 |
| Personnel | 4 |
| Pathogen | 4 |
| Panel | 4 |
| PRISMA | 4 |
| PLoS | 4 |
| PI3K | 4 |
| Overview | 4 |
| Other | 4 |
| Okba | 4 |
| Potential | 4 |
| Occupational | 4 |
| Oboho | 4 |
| OR | 4 |
| Notes | 4 |
| Neoromicia | 4 |
| Near | 4 |
| NT | 4 |
| NJ | 4 |
| NIAID | 4 |
| ND | 4 |
| nan | 4 |
| Mycophenolic | 4 |
| System | 4 |
| Policy | 4 |
| Nab | 4 |
| Prevalence | 4 |
| SNPs | 4 |
| Student | 4 |
| Station | 4 |
| Prism | 4 |
| Stata | 4 |
| Stalin | 4 |
| Species | 4 |
| SnpEff | 4 |
| Shalhoub | 4 |
| Sci | 4 |
| Sanger | 4 |
| Sahara | 4 |
| Sabir | 4 |
| SPSS | 4 |
| Spring | 4 |
| SI | 4 |
| Ramadan | 4 |
| Q | 4 |
| SFP | 4 |
| Promega | 4 |
| R0 | 4 |
| RVFV | 4 |
| RDT | 4 |
| Qom | 4 |
| S3 | 4 |
| RealStar | 4 |
| Reverse | 4 |
| Rhesus | 4 |
| zer | 4 |
| Helmand | 3 |
| Heinz | 3 |
| Head | 3 |
| HEV | 3 |
| HIV-1 | 3 |
| Haynes | 3 |
| Hanna | 3 |
| HVIG | 3 |
| Hemorrhagic | 3 |
| HRV | 3 |
| Hanan | 3 |
| Hung | 3 |
| High | 3 |
| Hijawi | 3 |
| Hillman | 3 |
| Hospitals | 3 |
| I2 | 3 |
| IHME | 3 |
| IL-1β | 3 |
| ITP | 3 |
| IVIG | 3 |
| H7 | 3 |
| IgG2a | 3 |
| Immunity | 3 |
| HEPA | 3 |
| George | 3 |
| H3N2 | 3 |
| GAUL | 3 |
| Fast | 3 |
| Info | 3 |
| Fatality | 3 |
| Feldmann | 3 |
| Fifth | 3 |
| Fluor | 3 |
| Force | 3 |
| Forest | 3 |
| Forni | 3 |
| GAPDH | 3 |
| GDP | 3 |
| H+L | 3 |
| Georgia | 3 |
| Gerber | 3 |
| Germline | 3 |
| Grand | 3 |
| Greater | 3 |
| Green | 3 |
| Ground | 3 |
| Guangzhou | 3 |
| Guard | 3 |
| Guidance | 3 |
| Infected | 3 |
| MER | 3 |
| Innovation | 3 |
| 3 | |
| Lymphopenia | 3 |
| MEF | 3 |
| MERS)-CoV | 3 |
| MERS-5HB | 3 |
| MERSCoV | 3 |
| MMR | 3 |
| MMS | 3 |
| MOHSA | 3 |
| MOPH | 3 |
| MSD | 3 |
| Mann | 3 |
| Ltd | 3 |
| Maps | 3 |
| Maria | 3 |
| Marion | 3 |
| Mass | 3 |
| Mauritania | 3 |
| Mersmab1 | 3 |
| Millennium | 3 |
| Milne | 3 |
| Mina | 3 |
| FP | 3 |
| Lu | 3 |
| Literature | 3 |
| Innovations | 3 |
| Jizan | 3 |
| Int | 3 |
| Intratracheal | 3 |
| Irbid | 3 |
| Isolates | 3 |
| Istanbul | 3 |
| JC57 | 3 |
| JED | 3 |
| JMoH | 3 |
| Jaffar | 3 |
| Jennifer | 3 |
| Jukes | 3 |
| License | 3 |
| Junctional | 3 |
| KAMC | 3 |
| KB | 3 |
| KFGH | 3 |
| Kandari | 3 |
| Kazakhstan | 3 |
| Lactoferrin | 3 |
| Land | 3 |
| Lanka | 3 |
| Libya | 3 |
| Failure | 3 |
| Background | 3 |
| F. | 3 |
| Azaibi | 3 |
| Alraddadi | 3 |
| Aly | 3 |
| Antimicrobial | 3 |
| Antiviral | 3 |
| Anwar | 3 |
| Arabic | 3 |
| Archive | 3 |
| Artibeus | 3 |
| Aspergillus | 3 |
| Author | 3 |
| BC | 3 |
| Algeria | 3 |
| BMC | 3 |
| Monoclonal | 3 |
| Baloxavir | 3 |
| Bartonella | 3 |
| Baydoun | 3 |
| Belgium | 3 |
| Bioinformatics | 3 |
| Biology | 3 |
| Box | 3 |
| Bunyaviridae | 3 |
| Aljan | 3 |
| Alexa | 3 |
| C57BL/6J | 3 |
| ALI | 3 |
| -)RNAs | 3 |
| -Saudi | 3 |
| 288–330(+/+ | 3 |
| 2d | 3 |
| 3D | 3 |
| 6:31629 | 3 |
| 6MP | 3 |
| A(H7N9 | 3 |
| AB | 3 |
| AG | 3 |
| AMA | 3 |
| Albarrak | 3 |
| Ab | 3 |
| Abdallat | 3 |
| Activity | 3 |
| Adenoid | 3 |
| Advisory | 3 |
| Aflatoxin | 3 |
| African | 3 |
| Agrawal | 3 |
| Ahssa | 3 |
| Air | 3 |
| Burden | 3 |
| CCHFV | 3 |
| Express | 3 |
| Ecology | 3 |
| DPP-4 | 3 |
| DPP4-expressing | 3 |
| DPPIV | 3 |
| De | 3 |
| DeMaria | 3 |
| Defense | 3 |
| Delta | 3 |
| Description | 3 |
| EM | 3 |
| ERGIC | 3 |
| Editor | 3 |
| Curr | 3 |
| Emergence | 3 |
| Enteritidis | 3 |
| Enterobacteriaceae | 3 |
| Envelope | 3 |
| Epi | 3 |
| Epidemiol | 3 |
| Erdman | 3 |
| Ethics | 3 |
| Euphrates | 3 |
| Exposure | 3 |
| DG | 3 |
| Cryo | 3 |
| CCL2 | 3 |
| CoV)-worldwide | 3 |
| CD | 3 |
| CHO | 3 |
| COPD | 3 |
| CXCL-1 | 3 |
| Cardiac | 3 |
| Carolina | 3 |
| Cary | 3 |
| Cas | 3 |
| CoV)-possible | 3 |
| CoV)-specific | 3 |
| CoVspecific | 3 |
| Crescent | 3 |
| Collaborative | 3 |
| Colorado | 3 |
| Conference | 3 |
| Contacts | 3 |
| Contamination | 3 |
| Convention | 3 |
| Conventions | 3 |
| Cooperation | 3 |
| Corporation | 3 |
| Course | 3 |
| Minister | 3 |
| Aden | 3 |
| Mountain | 3 |
| U.N. | 3 |
| anti | 3 |
| aplasia | 3 |
| arthralgia | 3 |
| bactrianus | 3 |
| baumannii | 3 |
| beta1a | 3 |
| betacoronaviruses | 3 |
| bp | 3 |
| buffalo | 3 |
| cobicistat | 3 |
| cytokeratin | 3 |
| cytomegalovirus | 3 |
| darunavir | 3 |
| deltacoronavirus | 3 |
| disease | 3 |
| doi:10.1186 | 3 |
| dpi | 3 |
| ebola | 3 |
| enterotoxin | 3 |
| fusogenic | 3 |
| general | 3 |
| globulin | 3 |
| goat | 3 |
| animal | 3 |
| anesthesia | 3 |
| alpha2a | 3 |
| Youden | 3 |
| VLP | 3 |
| VetScan | 3 |
| Vincent | 3 |
| Washington | 3 |
| Whitney | 3 |
| Wong | 3 |
| X | 3 |
| YS | 3 |
| Yamanaka | 3 |
| Yersinia | 3 |
| ZAM | 3 |
| alpha | 3 |
| Zealand | 3 |
| Zhao | 3 |
| Zhou | 3 |
| Zoo | 3 |
| Zumla | 3 |
| a2a | 3 |
| adenopathy | 3 |
| adenoviral | 3 |
| airways | 3 |
| alisporivir | 3 |
| gondii | 3 |
| hBoV | 3 |
| hDPP4-KI | 3 |
| virologic | 3 |
| sec | 3 |
| seropositivity | 3 |
| siRNAs | 3 |
| simplex | 3 |
| sulfamethoxazole | 3 |
| superspreader-1 | 3 |
| transchromosomic | 3 |
| transmembrane | 3 |
| tubotympanum | 3 |
| tympanocentesis | 3 |
| vitro | 3 |
| rst | 3 |
| www | 3 |
| www.cdc.gov/eid | 3 |
| www.nature.com/scientificdata | 3 |
| ® | 3 |
| Â10 | 3 |
| α-2a | 3 |
| μL | 3 |
| −20 | 3 |
| −4.7 | 3 |
| Mpro | 3 |
| s12889 | 3 |
| rmed | 3 |
| hMS-1 | 3 |
| methylprednisolone | 3 |
| homogenate | 3 |
| http:// | 3 |
| i.p | 3 |
| identifi | 3 |
| invitro | 3 |
| kappaB | 3 |
| kb | 3 |
| mDPP4 | 3 |
| mTOR | 3 |
| macroglossia | 3 |
| multicentre | 3 |
| rm | 3 |
| orange | 3 |
| p.o | 3 |
| pacos | 3 |
| palatini | 3 |
| paraformaldehyde | 3 |
| pipistrellus | 3 |
| postrash | 3 |
| preauricular | 3 |
| receptor | 3 |
| rhabdomyosarcoma | 3 |
| Units | 3 |
| leukocytosis | 3 |
| Tribune | 3 |
| RNeasy | 3 |
| PUIs | 3 |
| PUMC | 3 |
| Pandemic | 3 |
| Pascal | 3 |
| Pathogenicity | 3 |
| Pathology | 3 |
| Period | 3 |
| Persons | 3 |
| Pfu | 3 |
| Phase | 3 |
| Phlebovirus | 3 |
| Phosphorylation | 3 |
| Pi | 3 |
| Pneumococcal | 3 |
| Practices | 3 |
| Preferred | 3 |
| ProMed | 3 |
| Profiles | 3 |
| Protease | 3 |
| Protective | 3 |
| Pure | 3 |
| RDS | 3 |
| REGN3048 | 3 |
| PUI | 3 |
| PHE | 3 |
| PA | 3 |
| NPA | 3 |
| Multisystem | 3 |
| Treaty | 3 |
| Munster | 3 |
| Muslims | 3 |
| Müller | 3 |
| N. | 3 |
| N1/2012 | 3 |
| NCBI | 3 |
| NCT02845843 | 3 |
| NDM | 3 |
| NS2A | 3 |
| Orthopoxvirus | 3 |
| NSP1 | 3 |
| NSPs | 3 |
| NYS | 3 |
| Nagoya | 3 |
| Nucleocapsid | 3 |
| Nutrition | 3 |
| ORF3 | 3 |
| Oct | 3 |
| Old | 3 |
| Optimization | 3 |
| RH | 3 |
| Orf | 3 |
| RPMI | 3 |
| Societies | 3 |
| Statistical | 3 |
| Stillbirth | 3 |
| Strategic | 3 |
| Streptococcus | 3 |
| Suez | 3 |
| Susan | 3 |
| Syrian | 3 |
| Systems | 3 |
| T-705 | 3 |
| T330 | 3 |
| T330R | 3 |
| TRIzol | 3 |
| Tajkarimi | 3 |
| Tamin | 3 |
| Texas | 3 |
| Th2 | 3 |
| Therapeutics | 3 |
| Thiopurine | 3 |
| Todd | 3 |
| Trade | 3 |
| Recombination | 3 |
| Transcription | 3 |
| Trauma | 3 |
| Sri | 3 |
| TA | 3 |
| Social | 3 |
| Seed | 3 |
| Sindh | 3 |
| Rhabdomyosarcoma | 3 |
| Ron | 3 |
| SMC | 3 |
| ST-246 | 3 |
| Sameera | 3 |
| Sarigerme | 3 |
| Scale | 3 |
| Reviews | 3 |
| Rev | 3 |
| Section | 3 |
| Sept | 3 |
| Sero | 3 |
| Seroepidemiological | 3 |
| Seroprevalence | 3 |
| Services | 3 |
| Shedding | 3 |
| Sheikh | 3 |
| Shibo | 3 |
| Simon | 3 |
| RepoRts | 3 |
| HIB | 2 |
| HKU4-CoV | 2 |
| HM5 | 2 |
| HMPV | 2 |
| HG | 2 |
| Hadi | 2 |
| HPV | 2 |
| HR1P | 2 |
| HR2L | 2 |
| HRP | 2 |
| HBoV | 2 |
| Haematological | 2 |
| Hall | 2 |
| HE | 2 |
| Graduate | 2 |
| HBV | 2 |
| HACCP | 2 |
| Guan | 2 |
| Grivetti | 2 |
| Griffithsin | 2 |
| Greig | 2 |
| Grebner | 2 |
| Graham | 2 |
| Government | 2 |
| Gomaa | 2 |
| Goals | 2 |
| Glomus | 2 |
| Hamilton | 2 |
| Glycopeptide | 2 |
| Hamdan | 2 |
| Hu/ | 2 |
| Hammadi | 2 |
| Holy | 2 |
| I529 | 2 |
| Glen | 2 |
| Hyderabad | 2 |
| Hwan | 2 |
| Hutchison | 2 |
| Hurler | 2 |
| Humanitarian | 2 |
| Huh7 | 2 |
| Hotomi | 2 |
| Hospitalised | 2 |
| Hosp | 2 |
| Hosmer | 2 |
| Honey | 2 |
| Hokkaido | 2 |
| Hao | 2 |
| Hilden | 2 |
| Higher | 2 |
| Hif | 2 |
| Hepatitis | 2 |
| Hematol | 2 |
| Helsinki | 2 |
| Hellenic | 2 |
| Helicase | 2 |
| Hel | 2 |
| Headquarters | 2 |
| Hassan | 2 |
| Harris | 2 |
| Harcourt | 2 |
| Glob | 2 |
| FR | 2 |
| Glass | 2 |
| Facility | 2 |
| Figure-5 | 2 |
| Figure-2 | 2 |
| Figs | 2 |
| FigTree | 2 |
| Fig.2 | 2 |
| Fibrosis | 2 |
| Features | 2 |
| Fd | 2 |
| Farida | 2 |
| Faour | 2 |
| Fan | 2 |
| Faisalabad | 2 |
| Fahd | 2 |
| Facilities | 2 |
| Focus | 2 |
| 2 | |
| FL | 2 |
| FIG | 2 |
| F11 | 2 |
| Extraction | 2 |
| Expression | 2 |
| Expert | 2 |
| Event | 2 |
| Evans | 2 |
| Europeans | 2 |
| Eurasia | 2 |
| Eun | 2 |
| IACUC | 2 |
| Fischer | 2 |
| Foreign | 2 |
| Giuseppe | 2 |
| GPB | 2 |
| Gilead | 2 |
| Ghazi | 2 |
| Ghaleb | 2 |
| Germans | 2 |
| Geonyang | 2 |
| Generation | 2 |
| Geneious | 2 |
| GeneOne | 2 |
| Garland | 2 |
| Gao | 2 |
| Gammacoronavirus | 2 |
| Gamma | 2 |
| GRP78 | 2 |
| GI | 2 |
| Form | 2 |
| GD33 | 2 |
| GD-27 | 2 |
| GAR | 2 |
| G2 | 2 |
| Future | 2 |
| Furin | 2 |
| French | 2 |
| Free | 2 |
| Frank | 2 |
| Framework | 2 |
| Foster | 2 |
| Forschungsgemeinschaft | 2 |
| Formation | 2 |
| IAB | 2 |
| Lin | 2 |
| IBM | 2 |
| ICMJE | 2 |
| Laura | 2 |
| Lau | 2 |
| Late | 2 |
| Lanying | 2 |
| Langerhans | 2 |
| Landscape | 2 |
| Lama | 2 |
| Lab | 2 |
| LPV | 2 |
| LASSO | 2 |
| Kurram | 2 |
| Kodama | 2 |
| Ko | 2 |
| Klingbeil | 2 |
| Kita | 2 |
| Kit | 2 |
| Killerby | 2 |
| Kidney | 2 |
| Khudhair | 2 |
| Khoury | 2 |
| Kheir | 2 |
| Khalifa | 2 |
| Kevin | 2 |
| Kayvon | 2 |
| Kayali | 2 |
| Karachi | 2 |
| Kang | 2 |
| Kamel | 2 |
| Ka | 2 |
| Law | 2 |
| Layers | 2 |
| Lemeshow | 2 |
| MCP-1 | 2 |
| Ma | 2 |
| MSSA | 2 |
| MS | 2 |
| MR | 2 |
| MPV | 2 |
| MOFT | 2 |
| MMUP | 2 |
| MMA | 2 |
| MK | 2 |
| MIS | 2 |
| MIRACLE | 2 |
| MHC | 2 |
| MEGA | 2 |
| MCMC | 2 |
| Leone | 2 |
| MCM | 2 |
| MC | 2 |
| MAVS | 2 |
| MALR | 2 |
| Lymphoma | 2 |
| Luxor | 2 |
| Livanda | 2 |
| Little | 2 |
| Eskimos | 2 |
| Limited | 2 |
| Lim | 2 |
| Lia | 2 |
| Lessons | 2 |
| KOR | 2 |
| KE | 2 |
| KCDCP | 2 |
| ISA51 | 2 |
| Immunobiology | 2 |
| Immuno | 2 |
| Illinois | 2 |
| IgGs | 2 |
| IgG1 | 2 |
| Iftar | 2 |
| Ifn | 2 |
| Ibri | 2 |
| Ibrahim | 2 |
| Ian | 2 |
| IVI | 2 |
| IUGR | 2 |
| ISH | 2 |
| IPCC | 2 |
| Import | 2 |
| IMM | 2 |
| IMI | 2 |
| IMDM | 2 |
| IM | 2 |
| IL-7 | 2 |
| IL-1 | 2 |
| IL)-1β | 2 |
| IID | 2 |
| IFPRI | 2 |
| IFNα2b | 2 |
| IFNAR | 2 |
| IFIT1 | 2 |
| ICTV | 2 |
| Immunocompromised | 2 |
| Incidence | 2 |
| KAIMRC | 2 |
| Jackson | 2 |
| K18 | 2 |
| K. | 2 |
| Jörg | 2 |
| Julia | 2 |
| Joo | 2 |
| Joint | 2 |
| Johani | 2 |
| Jin | 2 |
| Jianping | 2 |
| Jeju | 2 |
| Japanese | 2 |
| Jakob | 2 |
| Jahdali | 2 |
| Iype | 2 |
| Indiana | 2 |
| Items | 2 |
| Italian | 2 |
| Isothermal | 2 |
| Ismail | 2 |
| Interspecies | 2 |
| Internal | 2 |
| Integrated | 2 |
| Insurance | 2 |
| Inspection | 2 |
| Innate | 2 |
| Information | 2 |
| Industry | 2 |
| Indonesia | 2 |
| Etzioni | 2 |
| Cancer | 2 |
| Eradication | 2 |
| Arbidol | 2 |
| BSE | 2 |
| BOX | 2 |
| B0AT1 | 2 |
| Ayman | 2 |
| Authorities | 2 |
| Austria | 2 |
| Australian | 2 |
| Atlanta | 2 |
| Aswan | 2 |
| Assiut | 2 |
| Assay | 2 |
| Aron | 2 |
| Area | 2 |
| Ar | 2 |
| Badawi | 2 |
| Appraisal | 2 |
| Application | 2 |
| Appendix | 2 |
| Antihuman | 2 |
| Anthony | 2 |
| AngI | 2 |
| Andrew | 2 |
| Analyses | 2 |
| Americans | 2 |
| Amblyomma | 2 |
| Amal | 2 |
| Alwan | 2 |
| Altona | 2 |
| Babu | 2 |
| Baharoon | 2 |
| Alsahafi | 2 |
| BioMed | 2 |
| Brucella | 2 |
| Brook | 2 |
| Breisinger | 2 |
| Brain | 2 |
| Bovismorbificans | 2 |
| Bordeaux | 2 |
| Bolukbasi | 2 |
| Blood | 2 |
| Blom | 2 |
| Biopsy | 2 |
| Biomarkers | 2 |
| Biolabs | 2 |
| Biodefense | 2 |
| BioCryst | 2 |
| Balochistan | 2 |
| Bio | 2 |
| Binding | 2 |
| Bernard | 2 |
| Belshe | 2 |
| Bekaa | 2 |
| Baş | 2 |
| Bausher | 2 |
| Basel | 2 |
| Barr | 2 |
| Barney | 2 |
| Bardshaw | 2 |
| Bank | 2 |
| Bandar | 2 |
| Altayyar | 2 |
| Alphacoronavirus | 2 |
| Budget | 2 |
| 3C | 2 |
| AP | 2 |
| AO | 2 |
| ANOVA | 2 |
| AKI | 2 |
| AK | 2 |
| ADEM | 2 |
| ADAM17 | 2 |
| ACE-2 | 2 |
| AA | 2 |
| A288L | 2 |
| 3F | 2 |
| 3E | 2 |
| 3CL | 2 |
| 3B | 2 |
| AWS | 2 |
| 3A | 2 |
| 2D | 2 |
| 2C | 2 |
| 2'-Omethylation | 2 |
| 1a | 2 |
| 1C | 2 |
| 141st | 2 |
| .05 | 2 |
| -drug | 2 |
| -Republic | 2 |
| -5 | 2 |
| -3 | 2 |
| Macaca | 2 |
| ARK | 2 |
| Abcam | 2 |
| Alpacas | 2 |
| Adjunctive | 2 |
| Alliance | 2 |
| Alharbi | 2 |
| Alghamedi | 2 |
| Alghamdi | 2 |
| Alenazi | 2 |
| Aldaghestani | 2 |
| Albert | 2 |
| Airway | 2 |
| Agostini | 2 |
| Agence | 2 |
| Age | 2 |
| Aeromonas | 2 |
| Administrative | 2 |
| Adenovirus | 2 |
| Abdul | 2 |
| Adenoidectomy | 2 |
| Adana | 2 |
| Adam | 2 |
| AdVs | 2 |
| Ad5.MERS | 2 |
| Action | 2 |
| Act | 2 |
| Abudayah | 2 |
| Abstract | 2 |
| Absence | 2 |
| Abs | 2 |
| Abou | 2 |
| Abedi | 2 |
| Brussels | 2 |
| Buliva | 2 |
| Epstein | 2 |
| Dean | 2 |
| Dipeptidylpeptidase | 2 |
| Differential | 2 |
| Dhahira | 2 |
| Dhafra | 2 |
| Deutsche | 2 |
| Descriptive | 2 |
| Democratic | 2 |
| Deltacoronavirus | 2 |
| Delivery | 2 |
| Delhi | 2 |
| Definition | 2 |
| Decision | 2 |
| Death | 2 |
| Daniel | 2 |
| Directorate | 2 |
| Daechung | 2 |
| DDP | 2 |
| D14 | 2 |
| D12 | 2 |
| Cytokines | 2 |
| Cytokine | 2 |
| Cystic | 2 |
| Cyclophilins | 2 |
| Current | 2 |
| Culture | 2 |
| Cterminal | 2 |
| CsA | 2 |
| Croup | 2 |
| Director | 2 |
| Disclosure | 2 |
| Creutzfeldt | 2 |
| Effectiveness | 2 |
| Enterobacter | 2 |
| Energy | 2 |
| Endosomal | 2 |
| Endemic | 2 |
| Emmie | 2 |
| Elsevier | 2 |
| Elkheir | 2 |
| Elizabeth | 2 |
| Eleven | 2 |
| Elasha | 2 |
| Eid | 2 |
| Egger | 2 |
| Effects | 2 |
| Effect | 2 |
| Disulfiram | 2 |
| Edition | 2 |
| Economist | 2 |
| Economics | 2 |
| Early | 2 |
| ESBL | 2 |
| EQA | 2 |
| E1 | 2 |
| Drugs | 2 |
| Donnelly | 2 |
| Dong | 2 |
| Domestic | 2 |
| Domain | 2 |
| Doctor | 2 |
| Critically | 2 |
| CpG | 2 |
| C(T | 2 |
| CPV | 2 |
| Chae | 2 |
| Chad | 2 |
| Cerumen | 2 |
| Cd | 2 |
| Cauchemez | 2 |
| Canadian | 2 |
| Camostat | 2 |
| Camelids | 2 |
| Cambridge | 2 |
| Callithrix | 2 |
| California | 2 |
| CXCL10 | 2 |
| CREST | 2 |
| CPE | 2 |
| Checklist | 2 |
| COVID- | 2 |
| COVID | 2 |
| CND | 2 |
| CK | 2 |
| CD68 | 2 |
| CD13 | 2 |
| CCTV | 2 |
| CCL81 | 2 |
| CCL-5 | 2 |
| CCL-3 | 2 |
| CCL-2 | 2 |
| CBD | 2 |
| C1 | 2 |
| Change | 2 |
| Chile | 2 |
| Cowling | 2 |
| Complications | 2 |
| Cov-2 | 2 |
| Counting | 2 |
| Countermeasures | 2 |
| Corticosteroids | 2 |
| Corp | 2 |
| Coronavirinae | 2 |
| Corley | 2 |
| Convalescent | 2 |
| Continued | 2 |
| Container | 2 |
| Cong | 2 |
| Concern | 2 |
| Comprehensive | 2 |
| Company | 2 |
| Chlamydia | 2 |
| Commodity | 2 |
| Combination | 2 |
| Columbia | 2 |
| Coinfection | 2 |
| Code | 2 |
| Clusters | 2 |
| Close | 2 |
| Clin | 2 |
| Climate | 2 |
| Clery | 2 |
| Christian | 2 |
| Chou | 2 |
| Cho | 2 |
| Mabs | 2 |
| Household | 2 |
| Macaques | 2 |
| Susanna | 2 |
| Zyad | 2 |
| Zoonoses | 2 |
| Zhongshan | 2 |
| Zabadani | 2 |
| Yusen | 2 |
| Yuan | 2 |
| Yasser | 2 |
| Yaseen | 2 |
| Yanfeng | 2 |
| Yan | 2 |
| YS110 | 2 |
| Y. | 2 |
| Xiaowen | 2 |
| XT | 2 |
| Woo | 2 |
| Women | 2 |
| Windows | 2 |
| Widagdo | 2 |
| Western | 2 |
| Wernery | 2 |
| Welch | 2 |
| Week | 2 |
| Website | 2 |
| Weber | 2 |
| Web | 2 |
| Watkins | 2 |
| Water | 2 |
| Watanabe | 2 |
| War | 2 |
| aalo | 2 |
| act | 2 |
| adenoidectomy | 2 |
| b978 | 2 |
| clavulanate | 2 |
| clarithromycin | 2 |
| chloramphenicol | 2 |
| chicken | 2 |
| chemoattractant | 2 |
| chanay | 2 |
| caspofungin | 2 |
| carcinoma | 2 |
| cantly | 2 |
| canal | 2 |
| c2018 | 2 |
| blue | 2 |
| baloxavir | 2 |
| b1a | 2 |
| airway | 2 |
| audiometry | 2 |
| associated | 2 |
| assembly | 2 |
| arytenoid | 2 |
| antiprotozoal | 2 |
| anteroposterior | 2 |
| anterior | 2 |
| ankara | 2 |
| angiotensinogen | 2 |
| and/ | 2 |
| amiloride | 2 |
| alveolar | 2 |
| alfacon-1 | 2 |
| Waldeyer | 2 |
| WI | 2 |
| W. | 2 |
| Tayeb | 2 |
| Tribal | 2 |
| Traveler | 2 |
| Transgenic | 2 |
| Training | 2 |
| Toxoplasma | 2 |
| Tourism | 2 |
| Tian | 2 |
| Thornburg | 2 |
| Thogotovirus | 2 |
| Thebes | 2 |
| Th | 2 |
| Tennessee | 2 |
| Temporal | 2 |
| Taliban | 2 |
| Tripartite | 2 |
| Talag | 2 |
| Table- | 2 |
| TLR-3 | 2 |
| TIB | 2 |
| T579N | 2 |
| T32 | 2 |
| Synthesis | 2 |
| Switzerland | 2 |
| Sweden | 2 |
| Swannell | 2 |
| SvEv | 2 |
| Suvang | 2 |
| Sustainability | 2 |
| Trim55 | 2 |
| Trivedi | 2 |
| Virlogeux | 2 |
| V. | 2 |
| Viraemia | 2 |
| Vigilância | 2 |
| Vicugna | 2 |
| Viability | 2 |
| Vet | 2 |
| Validation | 2 |
| Vaccinia | 2 |
| VRP | 2 |
| VLPs | 2 |
| VHHs | 2 |
| VHH-83 | 2 |
| VHH | 2 |
| VACV | 2 |
| Urdu | 2 |
| Trust | 2 |
| Upstream | 2 |
| Updates | 2 |
| Update | 2 |
| Univariate | 2 |
| Unique | 2 |
| Ultrastructure | 2 |
| UNICEF | 2 |
| UNHCR | 2 |
| Typhi | 2 |
| Tympanometry | 2 |
| Ty | 2 |
| Turner | 2 |
| Tsiodras | 2 |
| colistin | 2 |
| control | 2 |
| convalescent | 2 |
| peak | 2 |
| rtPCR | 2 |
| ray | 2 |
| proprotein | 2 |
| prodrug | 2 |
| ppNT | 2 |
| poly_id | 2 |
| poly(I | 2 |
| pneumocyte | 2 |
| pneumococcus | 2 |
| picobirnaviruses | 2 |
| perivascular | 2 |
| penicillin | 2 |
| pegylated | 2 |
| pVax1-S | 2 |
| s00705 | 2 |
| p=0·054 | 2 |
| p=0·004 | 2 |
| otoscopy | 2 |
| oseltamivir | 2 |
| orthopoxvirus | 2 |
| orf1b | 2 |
| nsp15 | 2 |
| nsp14 | 2 |
| nsp10-nsp16 | 2 |
| nsp1-induced | 2 |
| novo | 2 |
| novel | 2 |
| nitazoxanide | 2 |
| s. | 2 |
| saxagliptin | 2 |
| nap10 | 2 |
| trimethoprim | 2 |
| ■ | 2 |
| Macroglossia | 2 |
| À80 | 2 |
| ¼ | 2 |
| year_start | 2 |
| www.veterinaryworld.org/Vol.12/October-2019/7.pdf | 2 |
| www.nature.com/scientificreports | 2 |
| www.nature.com/scientificdata/ | 2 |
| www.internationalbudget.org | 2 |
| vomer | 2 |
| viral | 2 |
| vildagliptin | 2 |
| tympanogram | 2 |
| triazole | 2 |
| sero | 2 |
| transchromosomal | 2 |
| trans | 2 |
| sulfisoxazole | 2 |
| stemcell | 2 |
| srep31629 | 2 |
| sphenopalatine | 2 |
| sitagliptin | 2 |
| silvestrol | 2 |
| sheep | 2 |
| serovar | 2 |
| serosurvey | 2 |
| seroepidemiological | 2 |
| seroepidemiologic | 2 |
| neutrophilia | 2 |
| m² | 2 |
| convertases | 2 |
| enterica | 2 |
| http://creativecommons.org/licenses/by/4.0/. | 2 |
| herpes | 2 |
| hemosiderin | 2 |
| hemoptysis | 2 |
| hamadryas | 2 |
| hMPV | 2 |
| h. | 2 |
| green | 2 |
| gentamicin | 2 |
| externa | 2 |
| exposure(s | 2 |
| ethics | 2 |
| erent | 2 |
| endothelia | 2 |
| humanhuman | 2 |
| encephalocele | 2 |
| emergency | 2 |
| el | 2 |
| donovani | 2 |
| disulfiram | 2 |
| defi | 2 |
| defensin-1 | 2 |
| cystic | 2 |
| cyclophilins | 2 |
| crystal | 2 |
| cricoarytenoid | 2 |
| cribriform | 2 |
| covid-19 | 2 |
| http://www.who.int/emergencies/mers-cov/en/ | 2 |
| hypoalbuminemia | 2 |
| mycophenolic | 2 |
| laryngotracheobronchitis | 2 |
| myalgias | 2 |
| myalgia | 2 |
| mucoepidermoid | 2 |
| month_start | 2 |
| monophosphoramidate | 2 |
| mice | 2 |
| mesylate | 2 |
| marboxil | 2 |
| mL/10 | 2 |
| m337 | 2 |
| lung | 2 |
| lipooligosaccharide | 2 |
| lat | 2 |
| laryngomalacia | 2 |
| iii | 2 |
| lactoferrin | 2 |
| lactam | 2 |
| kinome | 2 |
| ketamine | 2 |
| jacchus | 2 |
| itraconazole | 2 |
| isoflurane | 2 |
| international | 2 |
| interarytenoid | 2 |
| intensivists | 2 |
| institutional | 2 |
| incus | 2 |
| immunodeficiency | 2 |
| Susceptibility | 2 |
| trismus | 2 |
| Survival | 2 |
| Plant | 2 |
| ORF8b | 2 |
| ORF8 | 2 |
| ORF6 | 2 |
| ORF)1a | 2 |
| ODN | 2 |
| O157 | 2 |
| Nursing | 2 |
| Nurses | 2 |
| Number | 2 |
| Novavax | 2 |
| Nosocomial | 2 |
| Norway | 2 |
| Northern | 2 |
| Nonsurvivors | 2 |
| Nonhuman | 2 |
| Non | 2 |
| No | 2 |
| Nisreen | 2 |
| Nikolaos | 2 |
| Niger | 2 |
| Nidovirus | 2 |
| Nextera | 2 |
| Neutralizing | 2 |
| Neurological | 2 |
| Neeltje | 2 |
| Neck | 2 |
| NbMS10 | 2 |
| Natural | 2 |
| Native | 2 |
| ORFs | 2 |
| Ogle | 2 |
| Ohio | 2 |
| PRRO | 2 |
| Philips | 2 |
| Peyer | 2 |
| Persistence | 2 |
| Persian | 2 |
| Perl | 2 |
| Peco | 2 |
| Pb | 2 |
| Payne | 2 |
| Pathogens | 2 |
| Pathogenic | 2 |
| Paramyxoviridae | 2 |
| Pacific | 2 |
| PaO2 | 2 |
| PROSPERO | 2 |
| Oliver | 2 |
| PRKRA | 2 |